Proactive tobacco treatment offering free nicotine replacement therapy and telephone counselling for socioeconomically disadvantaged smokers: a randomised clinical trial

Steven S Fu, Michelle van Ryn, David Nelson, Diana J Burgess, Janet L Thomas, Jessie Saul, Barbara Clothier, John A Nyman, Patrick Hammett, Anne M Joseph, Steven S Fu, Michelle van Ryn, David Nelson, Diana J Burgess, Janet L Thomas, Jessie Saul, Barbara Clothier, John A Nyman, Patrick Hammett, Anne M Joseph

Abstract

Background: Evidenced-based tobacco cessation treatments are underused, especially by socioeconomically disadvantaged smokers. This contributes to widening socioeconomic disparities in tobacco-related morbidity and mortality.

Methods: The Offering Proactive Treatment Intervention trial tested the effects of a proactive outreach tobacco treatment intervention on population-level smoking abstinence and tobacco treatment use among a population-based sample of socioeconomically disadvantaged smokers. Current smokers (n=2406), regardless of interest in quitting, who were enrolled in the Minnesota Health Care Programs, the state's publicly funded healthcare programmes for low-income populations, were randomly assigned to proactive outreach or usual care. The intervention comprised proactive outreach (tailored mailings and telephone calls) and free cessation treatment (nicotine replacement therapy and intensive, telephone counselling). Usual care comprised access to a primary care physician, insurance coverage of Food and Drug Administration-approved smoking cessation medications, and the state's telephone quitline. The primary outcome was self-reported 6-month prolonged smoking abstinence at 1 year and was assessed by follow-up survey.

Findings: The proactive intervention group had a higher prolonged abstinence rate at 1 year than usual care (16.5% vs 12.1%, OR 1.47, 95% CI 1.12 to 1.93). The effect of the proactive intervention on prolonged abstinence persisted in selection models accounting for non-response. In analysis of secondary outcomes, use of evidence-based tobacco cessation treatments were significantly greater among proactive outreach participants compared with usual care, particularly combination counselling and medications (17.4% vs 3.6%, OR 5.69, 95% CI 3.85 to 8.40).

Interpretation: Population-based proactive tobacco treatment increases engagement in evidence-based treatment and is effective in long-term smoking cessation among socioeconomically disadvantaged smokers. Findings suggest that dissemination of population-based proactive treatment approaches is an effective strategy to reduce the prevalence of smoking and socioeconomic disparities in tobacco use.

Trial registration number: NCT01123967.

Keywords: Smoking cessation; Tobacco control.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Figures

Figure 1
Figure 1
Flow chart showing the enrolment, randomisation and follow-up of the study participants.

References

    1. Hiscock R, Bauld L, Amos A, et al. . Socioeconomic status and smoking: a review. Ann N Y Acad Sci 2012;1248:107–23. 10.1111/j.1749-6632.2011.06202.x
    1. Amos A, Bauld L, Clifford D, et al. . Tobacco control, inequalities in health and action at a local level. York: Public Health Research Consortium, 2011.
    1. Sharma A, Lewis S, Szatkowski L. Insights into social disparities in smoking prevalence using Mosaic, a novel measure of socioeconomic status: an analysis using a large primary care dataset. BMC Public Health 2010;10:755 10.1186/1471-2458-10-755
    1. Ahmed J, Agaku IT, O'Connor E, et al. . Current cigarette smoking among adults—United States, 2005–2013. MMWR Morb Mortal Wkly Rep 2014;63:1108–12.
    1. Schiller JS, Lucas JW, Ward BW, et al. . Summary health statistics for U.S. adults: National Health Interview Survey, 2010. Vital Health Stat 10 2012;252:1–207.
    1. Fu SS, Sherman SE, Yano EM, et al. . Ethnic disparities in the use of nicotine replacement therapy for smoking cessation in an equal access health care system. Am J Health Promot 2005;20:108–16. 10.4278/0890-1171-20.2.108
    1. Fu SS, Kodl MM, Joseph AM, et al. . Racial/Ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years. Cancer Epidemiol Biomarkers Prev 2008;17:1640–7. 10.1158/1055-9965.EPI-07-2726
    1. Cokkinides VE, Ward E, Jemal A, et al. . Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med 2005;28:119–22. 10.1016/j.amepre.2004.09.007
    1. Fiore MC, Jaen CR, Baker TB, et al. . Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, MD: USDHHS, Public Health Service, 2008.
    1. McMenamin SB, Halpin HA, Ibrahim JK, et al. . Physician and enrollee knowledge of Medicaid coverage for tobacco dependence treatments. Am J Prev Med 2004;26:99–104. 10.1016/j.amepre.2003.10.017
    1. McMenamin SB, Halpin HA, Bellows NM. Knowledge of Medicaid coverage and effectiveness of smoking treatments. Am J Prev Med 2006;31:369–74. 10.1016/j.amepre.2006.07.015
    1. Blumenthal DS. Barriers to the provision of smoking cessation services reported by clinicians in underserved communities. J Am Board Fam Med 2007;20:272–9. 10.3122/jabfm.2007.03.060115
    1. Browning K, Ferketich A, Salsberry P, et al. . Socioeconomic disparity in provider-delivered assistance to quit smoking. Nicotine Tob Res 2008;10:55–61. 10.1080/14622200701704905
    1. Houston T, Scarinci I, Person S, et al. . Patient smoking cessation advice by health care providers: the role of ethnicity, socioeconomic status, and health. Am J Public Health 2005;95:1056–61. 10.2105/AJPH.2004.039909
    1. Fu SS, Van ryn M, Burgess DJ, et al. . Proactive tobacco treatment for low income smokers: study protocol of a randomized controlled trial. BMC Public Health 2014;14:337 10.1186/1471-2458-14-337
    1. Abrams DB, Orleans CT, Niaura RS, et al. . Integrating individual and public health perspectives for tobacco treatment under managed health care: a combined stepped-care and matching model. Ann Behav Med 1996;18:290–304. 10.1007/BF02895291
    1. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health 1999;89:1322–7. 10.2105/AJPH.89.9.1322
    1. Hughes JR, Keely JP, Niaura RS, et al. . Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003;5:13–25. 10.1080/1462220031000070552
    1. DiClemente CC. Motivational interviewing and the stages of change. In: Miller WR, Rollnick S. Motivational interviewing: preparing people to change addictive behavior. New York: Guilford Press, 1991:191–202.
    1. Rollnick S, Miller W, Butler C. Motivational interviewing in health care. New York, NY: Guilford Press, 2008.
    1. Lai DT, Cahill K, Qin Y, et al. . Motivational interviewing for smoking cessation. Cochrane Database Syst Rev 2010;(1):CD006936.
    1. Zhu SH, Anderson CM, Tedeschi GJ, et al. . Evidence of real-world effectiveness of a telephone quitline for smokers: comment. NEJM 2002;347:1087–93. 10.1056/NEJMsa020660
    1. Fiore MC, Jaen CR. A clinical blueprint to accelerate the elimination of tobacco use. JAMA 2008;299:2083–5. 10.1001/jama.299.17.2083
    1. Biener L, Abrams DB. The contemplation ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol 1991;10:360–5. 10.1037/0278-6133.10.5.360
    1. Ibrahim JG, Lipsitz SR. Parameter estimation from incomplete data in binomial regression when the missing data mechanism is nonignorable. Biometrics 1996;52:1071–8. 10.2307/2533068
    1. Little RJA. Selection and pattern mixture models. In: Fitzmaurice G, Davidian M, Verbeke G, et al. eds. Advances in longitudinal data analysis. London, UK: CRC Press, 2008:409–31.
    1. Non-Disabled Adults. . (accessed 23 Dec 2015).
    1. Tobacco Cessation. . (accessed 23 Dec 2015).
    1. Rigotti NA, Bitton A, Kelley JK, et al. . Offering population-based tobacco treatment in a healthcare setting: a randomized controlled trial. Am J Prev Med 2011;41:498–503. 10.1016/j.amepre.2011.07.022
    1. Fu SS, Van ryn M, Sherman SE, et al. . Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial. JAMA Intern Med 2014;174:671–7. 10.1001/jamainternmed.2014.177
    1. Haas JS, Linder JA, Park ER, et al. . Proactive tobacco cessation outreach to smokers of low socioeconomic status: a randomized clinical trial. JAMA Intern Med 2015;175:218–26. 10.1001/jamainternmed.2014.6674
    1. 2013. (accessed 5 May 2015).
    1. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002;4:149–59.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner